Osiris Therapeutics to Cut 80 Jobs

Stem cell research firm Osiris Therapeutics will accelerate the transfer of its Osteocel unit to NuVasive, and terminate 80 jobs in its Osteocel unit.

The faster transfer of the Osteocel business, which Osiris had agreed to sell to NuVasive last year, would lead to a $30 million payment to Osiris.

Osiris has produced and marketed Osteocel since July 2005 for regenerating bone in orthopedic indications.

Osiris will cease manufacturing at its Columbia, Maryland Osteocel facilities on March 31st.

Career Connect (From our other career blogs):

Employment News (Sponsored by EmploymentSpectator)
Following Your Passion-Literally! (Sponsored by iamnotastalker.com)
Job Search Advice from the CEO of TravelingCrossing (Sponsored by aharrisonbarnes.com)
Layoff News (Sponsored by LayOffWatch)

Testimonial of the Week

I was very pleased with the TravelingCrossing. I found a great position within a short amount of time … I definitely recommend this to anyone looking for a better opportunity.

Jose M Santa Cruz, CA

+ Read More Testimonial

Only TravelingCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.

We have more jobs than any other job board.
We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites
We collect jobs from more than 4,429,376 websites and post them on our site.
We are private, and therefore far fewer people are applying for the jobs on our site than are applying for those on public job boards.